Related Experiment Video
Updated: Aug 10, 2026
09:07
Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
Published on: August 15, 2017
Medication resistance and clinical response to electroconvulsive therapy
J Prudic1, H A Sackeim, D P Devanand
1Dept. of Biological Psychiatry, New York State Psychiatric Institute, NY 10032.
Psychiatry Research
|March 1, 1990
Summary
Medication resistance predicts electroconvulsive therapy (ECT) response in major depression. Patients unresponsive to adequate medication trials before ECT were less likely to benefit, highlighting resistance as a key factor.
Area of Science:
- Psychiatry
- Neuroscience
- Clinical Medicine
Background:
- Major depressive disorder is a leading cause of disability worldwide.
- Treatment resistance is common in major depression, necessitating alternative therapies.
- Electroconvulsive therapy (ECT) is an effective treatment for severe or treatment-resistant depression.
Purpose of the Study:
- To investigate the relationship between prior medication resistance and short-term clinical response to bilateral electroconvulsive therapy (ECT).
- To determine if medication resistance predicts ECT efficacy in patients with major depressive disorder.
Main Methods:
- A cohort of 53 patients meeting Research Diagnostic Criteria for major depressive disorder were assessed.
- The strength of pharmacological treatment trials prior to ECT was systematically rated.
- Short-term clinical response to bilateral ECT was evaluated.
Main Results:
- Patients who had not responded to adequate pre-ECT pharmacotherapy were significantly less likely to respond to ECT.
- Medication resistance demonstrated a predictive value for ECT's therapeutic effects.
- Adequacy of prior pharmacological trials was a key differentiator in ECT response.
Conclusions:
- Prior medication resistance is a significant predictor of ECT non-response in major depression.
- This finding has implications for patient selection and treatment planning for ECT.
- Understanding medication resistance can optimize the use of ECT in treatment-resistant depression.
More Related Videos
Related Concept Videos
01:28Psychosis and Antipsychotic Drugs: Overview
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:24Mania and Antimanic Drugs: Overview
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...
01:24Epilepsy and Seizures: Overview
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:30Electroconvulsive Therapy
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...